In one of the first major races of 2026, some candidates are focusing on an issue that has proven to motivate their base but ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...
She was a pioneer in American abstract art, achieving multiple firsts and breaking barriers for women in the visual arts,” ...
Inquirer Opinion on MSN
Hail to the FLP bar topnotchers and passers
The Foundation for Liberty and Prosperity hails and congratulates its 14 scholars who topped or passed the 2025 bar ...
"We’ve got to leverage every bit of talent that this nation has,” the retired general told trans troops with more than 20 ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...
I don’t think it’s quite done,” he says, as fans streams for the exits to beat the coming rush of traffic and students chant ...
The Supreme Court heard arguments over laws passed by more than half the states to bar transgender girls and women from ...
As Dr. Christopher Bellavita observed in his 2008 article "Changing Homeland Security: What is Homeland Security?", "The ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
PPA constraints need to be paired with real workloads, but they also need to be flexible to account for future changes.
Lithium-ion battery incidents—ranging from fires and explosions to toxic emissions—pose growing threats to public safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback